“There are unlimited possibilities for eCOA to help clinical trial sponsors effectively and efficiently develop new medical treatments, and ERT’s innovative solutions and services are clearly leading the way.”
PHILADELPHIA (PRWEB) October 13, 2014
ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced the appointment of Ron Sullivan to the position of Executive Vice President and Product Line Executive for electronic Clinical Outcome Assessments (eCOA). Mr. Sullivan brings more than 20 years global business acumen to ERT, including extensive experience in the medical device and healthcare industries.
Prior to joining ERT, Mr. Sullivan was Global Vice President of Product Development and Portfolio Management at GE Healthcare Surgery, where he was responsible for new product R&D and product life cycle management across a $500 million surgery business, including four global design centers. His prior roles at GE include Global Vice President and General Manager, Surgical Imaging; Vice President, Global Lean Six Sigma and Quality Operations; and Vice President and General Manager, Americas Services Marketing. Mr. Sullivan holds a B.S. in Mechanical Engineering from the University of Minnesota and is an active participant in the community, including board membership for the University of Utah Innovation Center.
Mr. Sullivan is joining a well established team of ERT product line executives that will now have nearly 70 years of combined experience developing innovative solutions to meet the needs of the biopharmaceutical and healthcare industries. “I’m delighted to join this experienced group of ERT leaders at this exciting time in the clinical trials industry,” said Sullivan. “There are unlimited possibilities for eCOA to help clinical trial sponsors effectively and efficiently develop new medical treatments, and ERT’s innovative solutions and services are clearly leading the way.”
Jim Corrigan, President and CEO of ERT, commented "We are all pleased that Ron will be joining the executive management team at ERT. In his position, Ron will be responsible for planning and executing the strategy for the eCOA product line, as well as serve as the executive lead for our Pittsburgh location. "Ron is very well positioned to lead ERT’s eCOA initiatives, which is particularly important in reaching the bright future we all predict for ERT."
For more information on ERT’s executive management team, visit http://www.ert.com/about-us.
ERT (http://www.ert.com) is a leading provider of high-quality patient safety and efficacy endpoint data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle. ERT delivers the most widely deployed solutions in centralized cardiac safety, respiratory services, suicide risk assessment and Clinical Outcome Assessments (COAs) – which includes patient, clinician, and observer reported outcomes. By efficiently integrating these solutions through a system built upon a scientific and regulatory foundation, ERT collects, analyzes, and delivers safety and efficacy data critical to the approval, labeling, and reimbursement of pharmaceutical products. ERT is a global organization with headquarters in Philadelphia, PA and offices throughout the U.S., U.K., Japan, and Germany.